1. Home
  2. SEAT vs XLO Comparison

SEAT vs XLO Comparison

Compare SEAT & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivid Seats Inc.

SEAT

Vivid Seats Inc.

HOLD

Current Price

$8.03

Market Cap

60.6M

Sector

Industrials

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.25

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEAT
XLO
Founded
2001
2016
Country
United States
United States
Employees
768
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.6M
49.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SEAT
XLO
Price
$8.03
$8.25
Analyst Decision
Buy
Buy
Analyst Count
8
1
Target Price
$18.06
$28.00
AVG Volume (30 Days)
109.0K
32.1K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,766,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.60
$168.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$1.42
$0.46
52 Week High
$35.00
$9.25

Technical Indicators

Market Signals
Indicator
SEAT
XLO
Relative Strength Index (RSI) 51.55 53.90
Support Level $5.72 $0.62
Resistance Level $10.27 $9.03
Average True Range (ATR) 0.99 0.49
MACD -0.09 -0.02
Stochastic Oscillator 40.59 51.88

Price Performance

Historical Comparison
SEAT
XLO

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: